Summary
InterMune, Inc. was founded in Brisbane, California, 1998. They are a biotechnical company whose primary focus is on creating and commercializing therapies related to pulmonary disease, infectious disease, and cancer. InterMune, Inc.'s entire product line is focused on improving comfort in patients while they receive their treatments.
Actimmune is a bioengineered interferon gamma launched by InterMune Pharmaceuticals in 1990. Actimmune has been approved by the FDA to hinder infections in patients with chronic granulomatous disease and severe to malignant osteopetrosis. Actimmune is administered as an injection.
Eligibility
Actimmune Patient Assistance Program is provided by InterMune, Inc.. They offer a 90 day supply of Actimmune at a reduced cost to those who are eligible for the program. Eligibility is based off of the following requirements:
What´s Next?
Fill out the program enrollment form located to your right. If you don't see an enrollment form available please call InterMune Pharmaceuticals program directly. After filling out the enrollment form please bring the form to your doctor for proper signatures and procedures. Do not forget a self stamped envelope for them to mail in your application to the program.
Other Tips
- If you have any questions please call the InterMune Pharmaceuticals program directly.
- Fill out as much of the information on the enrollment form as possible. The more information you have pre-filled the easier the progrm is to enroll in.
- Write down the refill dates for your program and set a reminder here on PatientAssistance.com so that you don't run out of medication.
- Do not write messy on your forms as this will delay any response.
- Call and write thank you notes to AAI Pharma Inc. program. Without their help millions of people will be without medication.